Feklisova L V
Vestn Ross Akad Med Nauk. 2005(12):17-24.
The article presents the results of long-term (several years) use of Russian bifido- and lactocontaing probiotics and data on the clinicolaboratory effectiveness of bifidumbacterin forte, probifor, bifidin, bifilis, calcidum, florin forte, acipol and acilact in children with various intestinal infections of known and unknown etiology. The presented results were obtained by studies conducted according to the requirements of The Governmental Program of L. A. Tarasevich State Institute of Standartization and Medical Biological Preparation Control, which included randomization of groups of patients receiving codified preparations or placebo according to their age, nosology, the degree of the process severity, premorbid status, and the time when the treatment was started. Each of the programs included several hundreds of children, receiving probiotics; in which of the programs the studies were multicentered. The courses of treatment with probiotics were short (1 to 2 weeks). No significant adverse effects were observed.
本文介绍了长期(数年)使用俄罗斯含双歧杆菌和乳酸菌的益生菌的结果,以及双歧杆菌素强力型、普罗比福、双歧菌素、双歧利、钙尔奇、弗洛林强力型、阿西波尔和阿西拉克在患有各种已知和未知病因肠道感染儿童中的临床实验室有效性数据。所呈现的结果是根据L.A.塔拉谢维奇国家标准化与医学生物制剂控制研究所政府项目的要求进行的研究得出的,该研究包括根据患者的年龄、疾病分类、病情严重程度、病前状态以及开始治疗的时间,对接受编码制剂或安慰剂的患者组进行随机分组。每个项目都包括数百名接受益生菌治疗的儿童;其中一些项目的研究是多中心的。益生菌治疗疗程较短(1至2周)。未观察到明显的不良反应。